Obligation Israel Chemicals Limited 6.375% ( IL0028103310 ) en USD

Société émettrice Israel Chemicals Limited
Prix sur le marché refresh price now   95.92 %  ⇌ 
Pays  Israel
Code ISIN  IL0028103310 ( en USD )
Coupon 6.375% par an ( paiement semestriel )
Echéance 31/05/2038



Prospectus brochure de l'obligation Israel Chemicals Limited IL0028103310 en USD 6.375%, échéance 31/05/2038


Montant Minimal 1 000 USD
Montant de l'émission 600 000 000 USD
Notation Standard & Poor's ( S&P ) BBB- ( Qualité moyenne inférieure )
Notation Moody's /
Prochain Coupon 30/05/2024 ( Dans 34 jours )
Description détaillée L'Obligation émise par Israel Chemicals Limited ( Israel ) , en USD, avec le code ISIN IL0028103310, paye un coupon de 6.375% par an.
Le paiement des coupons est semestriel et la maturité de l'Obligation est le 31/05/2038
L'Obligation émise par Israel Chemicals Limited ( Israel ) , en USD, avec le code ISIN IL0028103310, a été notée BBB- ( Qualité moyenne inférieure ) par l'agence de notation Standard & Poor's ( S&P ).







INDENTURE

between

ISRAEL CHEMICALS LTD.,
as Issuer

and
HSBC BANK USA, NATIONAL ASSOCIATION
as Trustee

____________________________________
Dated as of May 31, 2018
____________________________________

$600,000,000 6.375% Senior Notes due 2038






TABLE OF CONTENTS
Page
ARTICLE 1 DEFINITIONS AND CONSTRUCTION; INDENTURE TO CONSTITUTE
CONTRACT; AGENCY ................................................................................................................ 1
SECTION 1.1 Definitions; Construction .............................................................................1
SECTION 1.2 Indenture to Constitute Contract ..................................................................2
ARTICLE 2 THE NOTES .............................................................................................................. 2
SECTION 2.1 Authorization, Amount, Terms and Issuance of Notes ................................2
SECTION 2.2 Form and Dating ..........................................................................................3
SECTION 2.3 Execution and Authentication ......................................................................4
SECTION 2.4 Securities Registrar and Paying Agent ........................................................5
SECTION 2.5 Paying Agent to Hold Money ......................................................................5
SECTION 2.6 Holder Lists ..................................................................................................6
SECTION 2.7 Transfer and Exchange ................................................................................6
SECTION 2.8 Replacement Notes. ...................................................................................10
SECTION 2.9 Outstanding Notes ......................................................................................10
SECTION 2.10 Treasury Notes ...........................................................................................10
SECTION 2.11 Temporary Notes .......................................................................................10
SECTION 2.12 Cancellation ...............................................................................................11
SECTION 2.13 Defaulted Interest .......................................................................................11
SECTION 2.14 CUSIP; ISIN ..............................................................................................11
SECTION 2.15 Payments to be Made by Paying Agent; Deposit of Moneys ....................11
SECTION 2.16 Agents ........................................................................................................13
ARTICLE 3 REDEMPTION OF NOTES .................................................................................... 14
SECTION 3.1 Redemption at the Option of the Issuer .....................................................14
SECTION 3.2 Mandatory Redemption .............................................................................14
SECTION 3.3 Notice of Redemption ................................................................................16
SECTION 3.4 Notes Payable on Redemption Date ..........................................................17
SECTION 3.5 Selection of Notes to be Redeemed ...........................................................19
SECTION 3.6 Notes Redeemed in Part .............................................................................19
ARTICLE 4 COVENANTS ......................................................................................................... 19
SECTION 4.1 Affirmative Covenants ...............................................................................19
SECTION 4.2 Negative Covenants ...................................................................................23
ARTICLE 5 EVENTS OF DEFAULT; REMEDIES ................................................................... 27
SECTION 5.1 Events of Default .......................................................................................27
SECTION 5.2 Remedies Upon an Event of Default .........................................................29
SECTION 5.3 Judicial Proceedings Instituted by Trustee ................................................29







SECTION 5.4 Control by Holders .....................................................................................31
SECTION 5.5 Limitation on Suits by Holders ..................................................................32
SECTION 5.6 Undertaking to Pay Court Costs ................................................................32
SECTION 5.7 Unconditional Right to Receive Payment ..................................................33
SECTION 5.8 Application of Monies Collected by Trustee .............................................33
SECTION 5.9 Waiver of Appraisal, Valuation, Stay and Right to Marshalling ...............34
SECTION 5.10 Remedies Cumulative; Delay or Omission Not Waiver ............................34
ARTICLE 6 ACTS OF HOLDERS .............................................................................................. 35
SECTION 6.1 Acts of Holders ..........................................................................................35
SECTION 6.2 Purposes for Which Holders' Meeting May Be Called .............................36
SECTION 6.3 Call of Meetings by Trustee .......................................................................36
SECTION 6.4 The Issuer May Call Meeting ....................................................................37
SECTION 6.5 Persons Entitled to Vote at Meeting ..........................................................37
SECTION 6.6 Determination of Voting Rights; Conduct and Adjournment of
Meeting ......................................................................................................37
SECTION 6.7 Counting Votes and Recording Action of Meeting ...................................38
SECTION 6.8 Evidence of Action Taken by Holders .......................................................38
SECTION 6.9 Proof of Execution of Instruments and of Holding of Outstanding
Notes ..........................................................................................................39
SECTION 6.10 Notes Owned by Certain Persons Deemed Not Outstanding.....................39
SECTION 6.11 Right of Revocation of Action Taken; Acts of Holders Binding...............40
ARTICLE 7 SUPPLEMENTAL INDENTURES ........................................................................ 40
SECTION 7.1 Amendments and Supplements to Indenture Without Consent of
Holders .......................................................................................................40
SECTION 7.2 Amendments and Supplements to Indenture or Notes With Consent of
Holders .......................................................................................................41
SECTION 7.3 Trustee Authorized to Join in Amendments and Supplements; Reliance
on Counsel .................................................................................................42
SECTION 7.4 Effect of Supplemental Indentures or Amendments ..................................42
SECTION 7.5 Reference in Notes to Supplemental Indentures ........................................42
ARTICLE 8 SATISFACTION AND DISCHARGE; DEFEASANCE ....................................... 42
SECTION 8.1 Satisfaction and Discharge of Indenture ....................................................42
SECTION 8.2 Defeasance .................................................................................................43
SECTION 8.3 Survival of Obligations ..............................................................................45
SECTION 8.4 Application of Trust Money .......................................................................45
SECTION 8.5 Unclaimed Monies .....................................................................................46
SECTION 8.6 Reinstatement .............................................................................................46
ARTICLE 9 THE TRUSTEE ....................................................................................................... 46
SECTION 9.1 Certain Duties and Responsibilities of Trustee ..........................................46
SECTION 9.2 Certain Rights of Trustee ...........................................................................47








SECTION 9.3 Notice of Defaults ......................................................................................49
SECTION 9.4 Not Responsible for Recitals or Issuance of Notes ....................................50
SECTION 9.5 May Hold Notes .........................................................................................50
SECTION 9.6 Monies Held in Trust .................................................................................50
SECTION 9.7 Compensation; Reimbursement; Indemnification .....................................51
SECTION 9.8 Eligibility ...................................................................................................52
SECTION 9.9 Resignation and Removal; Appointment of Successor ..............................52
SECTION 9.10 Acceptance of Appointment by Successor Trustee ...................................54
SECTION 9.11 Merger, Conversion, Consolidation or Succession to Business ................54
SECTION 9.12 Authorization to Enter into Indenture ........................................................54
SECTION 9.13 Disqualification; Conflicting Interests .......................................................54
SECTION 9.14 Trustee's Application for Instructions from the Issuer ..............................54
ARTICLE 10 [RESERVED] ........................................................................................................ 55
ARTICLE 11 MISCELLANEOUS PROVISIONS ...................................................................... 55
SECTION 11.1 Third Party Beneficiaries ...........................................................................55
SECTION 11.2 Severability ................................................................................................55
SECTION 11.3 Substitute Notice ........................................................................................55
SECTION 11.4 Notices .......................................................................................................55
SECTION 11.5 Successors and Assigns..............................................................................56
SECTION 11.6 Section Headings .......................................................................................56
SECTION 11.7 Counterparts ...............................................................................................56
SECTION 11.8 GOVERNING LAW; SUBMISSION TO JURISDICTION;
CURRENCY INDEMNITY ......................................................................56
SECTION 11.9 WAIVER OF JURY TRIAL ......................................................................58
SECTION 11.10 Waiver of Immunity ...................................................................................58
SECTION 11.11 Legal Holidays ...........................................................................................58
SECTION 11.12 Limitation of Liability................................................................................58
SECTION 11.13 English Language.......................................................................................58
SECTION 11.14 Entire Agreement .......................................................................................58
SECTION 11.15 Survival ......................................................................................................59
SECTION 11.16 Officers' Certificates and Opinions of Counsel .........................................59
SECTION 11.17 Form of Certificates and Opinions Delivered to Trustee ...........................59
SECTION 11.18 Force Majeure ............................................................................................60
SECTION 11.19 U.S.A. Patriot Act ......................................................................................60
SECTION 11.20 Issuer Not a U.S. Tax Obligor ...................................................................60


APPENDIX A
Definitions
SCHEDULES
Schedule I
Notices









EXHIBITS

Exhibit A
Form of Note
Exhibit B
Form of Transfer
Exhibit C
Form of Transfer Restriction Legend
Exhibit D
Form of Certificate of Transfer







INDENTURE
This INDENTURE, dated as of May 31, 2018 (this "Indenture"), by and between
ISRAEL CHEMICALS LTD., a limited liability company incorporated under the laws of Israel
(the "Issuer"), and HSBC BANK USA, NATIONAL ASSOCIATION, a national banking
association, as trustee (in such capacity, together with its successors in such capacity, the
"Trustee").
W I T N E S S E T H:
WHEREAS, the Issuer has authorized the execution and delivery of this Indenture
to provide for the issuance of 6.375% Senior Notes due 2038 in an aggregate principal amount of
$600,000,000 (the "Initial Notes"), issuable as provided in this Indenture; and
WHEREAS, the execution and delivery of the Notes and of this Indenture have
been duly authorized and all things necessary to make the Notes, when executed by the Issuer
and authenticated by the Trustee, valid and binding legal obligations of the Issuer and to make
this Indenture a valid and binding agreement have been done;
NOW, THEREFORE, for and in consideration of the premises, the covenants
herein contained and the purchase of the Notes by the Holders thereof, it is mutually covenanted
and agreed, for the benefit of the parties hereto and the equal and proportionate benefit of all
Holders, as follows:
ARTICLE 1

DEFINITIONS AND CONSTRUCTION; INDENTURE TO CONSTITUTE
CONTRACT; AGENCY
Section 1.1
Definitions; Construction. (a) Capitalized terms used in this
Indenture shall have the respective meanings given to such terms in Appendix A attached hereto,
which Appendix A is hereby incorporated by reference herein;
(b)
all accounting terms not otherwise defined herein have the meanings
assigned to them in accordance with IFRS;
(c)
all references in this Indenture to designated "Articles," "Sections,"
"Schedules," "Exhibits" and other subdivisions are to the designated Articles, Sections,
Schedules, Exhibits and other subdivisions of this Indenture;
(d)
the words "herein," "hereof" and "hereunder" and other words of similar
import refer to this Indenture as a whole and not to any particular Article, Section, Exhibit or
other subdivision;
(e)
unless otherwise expressly specified, any agreement, contract or document
defined or referred to herein shall mean such agreement, contract or document as in effect as of
the Closing Date, as the same may thereafter be amended, restated, supplemented or otherwise
modified from time to time in accordance with the terms thereof and of this Indenture and







including any agreement, contract or document in substitution or replacement of any of the
foregoing;
(f)
unless the context clearly intends the contrary, pronouns having a
masculine or feminine gender shall be deemed to include the other;
(g)
any reference to any person (including the Issuer) shall include its
successors and assigns, and in the case of any Governmental Authority, any person succeeding to
its functions and capacities; and
(h)
any reference to "$" shall mean U.S. dollars, unless otherwise stated.
Section 1.2
Indenture to Constitute Contract. In consideration of the purchase
and acceptance of any or all of the Notes by those who shall hold the same from time to time, the
provisions of this Indenture shall be part of the contract of the Issuer with the Holders of the
Notes, and shall be deemed to be and shall constitute contracts between the Issuer, the Trustee
and the Holders from time to time of the Notes. The provisions, covenants and agreements
herein set forth to be performed by or on behalf of the Issuer shall be for the equal and ratable
benefit, protection and security of the Holders of any and all of the Notes. All of the Notes,
regardless of the time or times of their issuance or maturity, shall be of equal rank without
preference, priority or distinction of any of the Notes over any other except as expressly provided
in or pursuant to this Indenture.
ARTICLE 2

THE NOTES
Section 2.1
Authorization, Amount, Terms and Issuance of Notes (a) There
are to be authenticated and delivered on the Closing Date $600,000,000 principal amount of
Initial Notes. No Notes may be issued under this Indenture except in accordance with this
Article 2. Each of the Notes shall be issued in denominations of $1.00 and any amount in excess
thereof that is an integral multiple of $1.00.
The Issuer may, after giving notice to the Trustee and confirming to the Trustee
that all conditions precedent to the issuance of Additional Notes have been satisfied, issue
Additional Notes which shall have identical terms to the Notes (other than issue date, issue price
and, if applicable, the first Scheduled Payment Date and the first date from which interest will
accrue), together with the outstanding Notes, will be consolidated with and form a single series
of Notes; provided that Additional Notes will have the same CUSIP, ISIN (it being understood
that any reference in this Indenture to "ISIN" shall be deemed to include any equivalent thereto
issued by the TASE), Common Code or other identifying number of the outstanding Notes only
if such Additional Notes are either part of the same "issue" for U.S. federal income tax purposes
or issued pursuant to a "qualified reopening" for U.S. federal income tax purposes.
(b)
The aggregate principal amount of Notes (including any Additional Notes)
that may be authenticated and delivered under this Indenture is unlimited.
2







The terms and provisions contained in the Notes shall constitute, and are hereby
expressly made, a part of this Indenture, and the Issuer and the Trustee, by their execution and
delivery of this Indenture, expressly agree to such terms and provisions and to be bound thereby.
However, to the extent any provision of any Note conflicts with the express provisions of this
Indenture, the provisions of this Indenture shall govern and be controlling.
Section 2.2
Form and Dating (a) General. The Initial Notes and the Trustee's
or Authenticating Agent's certificate of authentication will be substantially in the form and
contain substantially the terms and conditions set forth in Exhibit A hereto. The Notes may have
notations, legends or endorsements required by law, stock exchange rule or usage, including the
provisions of the Applicable Procedures. Each Note will be dated the date of its authentication.
Notwithstanding any other provision of this Indenture, the Global Notes will not bear any legend
during such time as they are listed for trading on the TACT Institutional. Each Note shall bear
the Transfer Restriction Legend set forth on Exhibit C unless such Notes are to be listed on the
TACT Institutional.
(b)
Global Notes. Notes issued in global form will be substantially in the form
and contain substantially the terms and conditions set forth in Exhibit A hereto. Each Global
Note will represent such of the outstanding Notes as will be specified therein. Each Global Note
may from time to time be replaced in accordance with the Applicable Procedures with a new
Global Note in the event of a reduction or increase, as appropriate, of the amount of outstanding
Notes represented thereby to reflect an exchange or redemption pursuant to the terms of this
Indenture. Each new Global Note shall be deposited with the Depositary and shall reflect the
amount of outstanding Notes represented thereby.
Notes initially offered and resold to QIBs pursuant to Rule 144A under the
Securities Act or initially offered and resold in reliance on Regulation S shall be issued initially
in the form of one or more Global Notes, which shall be deposited with the Depositary, duly
executed by the Issuer and authenticated by the Trustee or the Authenticating Agent as
hereinafter provided. The aggregate principal amount of the Global Note may from time to time
be increased or decreased in accordance with the Applicable Procedures by replacement of the
Global Note with a new Global Note representing the aggregate principal amount outstanding of
Notes initially offered and resold pursuant to Rule 144A or initially offered and resold in reliance
on Regulation S and deposited with the Depositary.
(c)
Definitive Registered Notes. Definitive Registered Notes issued in
exchange for a Book-Entry Interest or a Definitive Registered Note, shall be issued in
accordance with this Indenture.
Definitive Registered Notes will be issued substantially in the form and contain
substantially the terms and conditions set forth in Exhibit A hereto.
(d)
Book-Entry Provisions. The Applicable Procedures shall be applicable to
the recordation, transfers and exchanges of Book-Entry Interests in the Global Notes held
through Participants. The rules and procedures of Euroclear and Clearstream shall be applicable
to any transfer or exchange of Book-Entry Interests in the Global Notes held through Euroclear
3







or Clearstream; provided that neither the Issuer nor the Trustee will have any obligation to
monitor the application of such rules and procedures.
(e)
Denomination. If the Notes are to be listed on the TACT Institutional, the
Notes shall be in denominations of $1.00 and integral multiples of $1.00 in excess thereof. If the
Notes are not to be listed on the TACT Institutional, the Notes shall be in denominations of
$2,000 and integral multiples of $1,000 or such other denominations as the Issuer shall authorize
from time to time.
Section 2.3
Execution and Authentication (a) At least one Authorized Officer
must sign the Notes for the Issuer by manual or facsimile signature.
If an Authorized Officer whose signature is on a Note no longer holds that office
at the time a Note is authenticated, the Note will nevertheless be valid.
A Note will not be valid until authenticated by the manual signature of a
Responsible Officer of the Trustee. The signature will be conclusive evidence that the Note has
been authenticated under this Indenture. Typographical and other minor errors or defects in any
signature executing or purporting to execute the Notes shall not affect the validity or
enforceability of any Note that has been duly authenticated and delivered by the Trustee.
The Trustee will, upon receipt of a written order of the Issuer signed by an
Authorized Officer (an "Authentication Order"), authenticate the Notes for original issue that
may be validly issued under this Indenture, including any Additional Notes. The aggregate
principal amount of Notes outstanding at any time may not exceed the aggregate principal
amount of Notes authorized for issuance by the Issuer pursuant to one or more Authentication
Orders, except as provided in Section 2.8 (Replacement Notes) hereof.
The Trustee may appoint an authenticating agent or agents (each an
"Authenticating Agent") acceptable to the Issuer to authenticate the Notes. An Authenticating
Agent may authenticate Notes whenever the Trustee may do so. Each reference in this Indenture
to authentication by the Trustee includes authentication by such agent. An authenticating agent
has the same rights as an Agent to deal with Holders or an Affiliate of the Issuer.
(b)
The Initial Notes issued on the Closing Date shall be dated as of the
Closing Date, shall be issued in the aggregate principal amount set forth in this Section 2.3 and
shall have a Stated Maturity and bear interest as set forth in this Section 2.3. Notes subsequently
issued pursuant to Section 2.7 (Transfer and Exchange) shall be dated as of the date of
authentication thereof.
On the Closing Date, the Issuer shall issue $600,000,000 aggregate principal
amount of the Initial Notes, which shall mature on May 31, 2038 (the "Scheduled Maturity
Date") and shall accrue interest as set forth in this Section 2.3;
(c)
Interest on the Initial Notes shall accrue at a rate of 6.375% per annum
(the "Interest Rate") from the most recent date to which interest has been paid or, if no interest
has been paid, from the Closing Date, and shall be paid semi-annually in arrears on each
4







Scheduled Payment Date, commencing November 30, 2018 and concluding on the Scheduled
Maturity Date.
(d)
Interest on the Initial Notes shall be computed on the basis of a 360-day
year of twelve 30-day months; provided that with respect to the interest period from the Closing
Date to the first Scheduled Payment Date, interest on the Initial Notes shall be computed on the
basis of a year of 365 days and payable for the actual number of days elapsed from and including
the Closing Date to but excluding the first Scheduled Payment Date.
(e)
If the Issuer is required to pay Additional Amounts pursuant to Section
4.1(f) (Taxation), the Issuer shall pay such Additional Amounts as additional interest on the
Initial Notes.
(f)
The principal amount of the Initial Notes is due and payable in full on the
Scheduled Maturity Date.
Section 2.4
Securities Registrar and Paying Agent. The Issuer will maintain
one or more offices or agencies (each, a "Paying Agent") where the Notes may be presented for
payment in Israel for so long as the Notes are outstanding. The initial Paying Agent in Israel for
the Notes will be the Issuer.
The Issuer will also maintain one or more registrars (each, a "Securities
Registrar") with offices in Israel, for so long as the Notes are listed on the TACT Institutional.
The Issuer shall be the initial Securities Registrar. The Securities Registrar shall maintain a
register reflecting ownership of Definitive Registered Notes (as defined herein) (the "Securities
Register") outstanding from time to time and will make payments on and facilitate transfer of
Definitive Registered Notes on behalf of the Issuer, provided that in the event the Issuer is not
the Securities Registrar, the register kept by, and at the registered office of, the Issuer shall
prevail in the event of any discrepancy between such register and the register held by the
Securities Registrar.
The Issuer may change the Paying Agent or Securities Registrar with prior notice
to the Trustee. For so long as the Notes are listed for trading on the TACT Institutional, the
Issuer will publish a notice of any change of Paying Agent or Securities Registrar through the
newswire service of Bloomberg, or if Bloomberg does not then operate, any similar agency, and,
to the extent and in the manner permitted by the Applicable Procedures, post such notice on the
official website of the TASE (http://maya.tase.co.il or any successor website thereto) in
accordance with Section 11.4 (Notices).
Section 2.5
Paying Agent to Hold Money. The Issuer will require each Paying
Agent (other than the Trustee in its capacity as Paying Agent), prior to such appointment, to
agree in writing and the Issuer, solely in its capacity as Paying Agent, hereby agrees, that such
Paying Agent shall hold all money held by the Paying Agent for the payment of the principal of,
Make-Whole Premiums (if any), Additional Amounts (if any) or interest on the Notes in trust for
the benefit of the Holders or the Trustee, and that such Paying Agent shall notify the Trustee of
any default by the Issuer or any other obligor of the Notes in making any payment and at any
time during the continuance of any such default, upon the written request of the Trustee,
5




Document Outline